TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Marker Research Plans Described; NCAB May Consider Asking For Special Study Section For Those Grants March 11, 1983
TCL Archive In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise October 24, 1986
